Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Islet Transplantation in Type 1 Diabetic Patients Using Campath-1H and Infliximab Induction

NCT00175266 is registered in ClinicalTrials.gov with University of Alberta as lead sponsor.

NCT NCT00175266
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00175266 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Islet Transplantation in Type 1 Diabetic Patients Using Campath-1H and Infliximab Induction
Lead sponsor
University of Alberta
Phase
Phase 2
Overall status
Completed
Start date
Not reported
Completion date
Not reported
Enrollment
12
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

type 1 diabetes